$13.01
Today
as of Jul 22, 16:53 ET
Last 30 days
Recent Press Releases & News
Pharming Group to report second quarter and first half 2026 financial results and provide business update on July 30
Pharming Group (ENXTAM:PHARM) Stock Gets Fair Value Boost As Joenja Progress Supports Growth Case
Pharming Group Says Marketing Application for Immunodeficiency Disorder Drug Accepted by FDA
Overview
52-week range
$9.54
$21
29% of range
Avg surprise (last 3)
-22.7%
Avg reaction (last 2)
-7.8%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-0.07 | $0.05 | -240.0% | +68.2% | -26.8% | earnings |
| Thu Jul 31, 2025 | Jun/2025 | $0.06 | $-0.10 | +160.0% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.22 | $-0.25 | +12.0% | — | +11.2% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Jul 30, 2026 | Jun/2026 | BMO | $0.20 | $0.06 | +233.3% |
Implied volatility — last 90 days
No IV snapshots yet for PHAR.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.